Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AMZ 002

Next Previous
Drug Profile

AMZ 002

Alternative Names: AMZ-002

Latest Information Update: 07 Mar 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ferring Pharmaceuticals
  • Developer Amzell
  • Class Antiepileptic drugs; Hormones
  • Mechanism of Action Hormone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Early infantile epileptic encephalopathy 2
  • New Molecular Entity Yes
  • Available For Licensing Yes - Infantile spasms

Highest Development Phases

  • Phase III Infantile spasms

Most Recent Events

  • 04 Mar 2024 Amring Pharmaceuticals is now called Nordic Pharma
  • 12 Apr 2022 Phase-III clinical trials in Infantile spasms (In children, In infants, Newly diagnosed) in France, Poland, Spain (Parenteral) (EudraCT2021-003015-26)
  • 25 Nov 2021 Amzell plans a phase III trial for Infantile spasms (In children, In infants, Newly diagnosed) in the US, Poland and Spain (Unspecified route) in December 2021 (NCT05128344) (EudraCT2021-003015-26)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top